Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gwenda Simons

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
BMC Rheumatology|August 23, 2022
The potential role of community pharmacy staff in reducing patient delay in consulting with symptoms of rheumatoid arthritis: a qualitative studyGwenda Simons, Nour Ismail, Karanbir Sandhu, et al.
Arthritis Research & Therapy|February 23, 2022
Systematic review of quantitative preference studies of treatments for rheumatoid arthritis among patients and at-risk populationsGwenda Simons, Joshua Caplan, Rachael L DiSantostefano, et al.
Patient Preference and Adherence|June 28, 2021
Taking into Account Patient Preferences: A Consensus Study on the Assessment of Psychological Dimensions Within Patient Preference StudiesSelena Russo, Dario Monzani, Cathy Anne Pinto, et al.
The Patient|August 30, 2023
Maximum Acceptable Risk Estimation Based on a Discrete Choice Experiment and a Probabilistic Threshold TechniqueJorien Veldwijk, Rachael Lynn DiSantostefano, Ellen Janssen, et al.
Research Involvement and Engagement|April 7, 2023
Patients as research partners in preference studies: learnings from IMI-PREFERMeredith Y Smith, Rosanne Janssens, A Cecilia Jimenez-Moreno, et al.
Rheumatology (Oxford, England)|September 6, 2022
Preferences for preventive treatments for rheumatoid arthritis: discrete choice survey in the UK, Germany and RomaniaGwenda Simons, Jorien Veldwijk, Rachael L DiSantostefano, et al.
BMC Rheumatology|March 20, 2019
Perceptions of first-degree relatives of patients with rheumatoid arthritis about lifestyle modifications and pharmacological interventions to reduce the risk of rheumatoid arthritis development: a qualitative interview studyGwenda Simons, Rebecca J Stack, Michaela Stoffer-Marx, et al.
BMJ Open|March 14, 2023
Treatment preferences for preventive interventions for rheumatoid arthritis: protocol of a mixed methods case study for the Innovative Medicines Initiative PREFER projectMarie Falahee, Gwenda Simons, Rachael L DiSantostefano, et al.
RMD Open|January 4, 2023
Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk toleranceGwenda Simons, Ellen M Janssen, Jorien Veldwijk, et al.
BMJ Open|July 1, 2016
Perceptions of risk and predictive testing held by the first-degree relatives of patients with rheumatoid arthritis in England, Austria and Germany: a qualitative studyRebecca J Stack, Michaela Stoffer, Mathias Englbrecht, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
BMC Rheumatology|August 23, 2022
The potential role of community pharmacy staff in reducing patient delay in consulting with symptoms of rheumatoid arthritis: a qualitative studyGwenda Simons, Nour Ismail, Karanbir Sandhu, et al.
Arthritis Research & Therapy|February 23, 2022
Systematic review of quantitative preference studies of treatments for rheumatoid arthritis among patients and at-risk populationsGwenda Simons, Joshua Caplan, Rachael L DiSantostefano, et al.
Patient Preference and Adherence|June 28, 2021
Taking into Account Patient Preferences: A Consensus Study on the Assessment of Psychological Dimensions Within Patient Preference StudiesSelena Russo, Dario Monzani, Cathy Anne Pinto, et al.
The Patient|August 30, 2023
Maximum Acceptable Risk Estimation Based on a Discrete Choice Experiment and a Probabilistic Threshold TechniqueJorien Veldwijk, Rachael Lynn DiSantostefano, Ellen Janssen, et al.
Research Involvement and Engagement|April 7, 2023
Patients as research partners in preference studies: learnings from IMI-PREFERMeredith Y Smith, Rosanne Janssens, A Cecilia Jimenez-Moreno, et al.
Rheumatology (Oxford, England)|September 6, 2022
Preferences for preventive treatments for rheumatoid arthritis: discrete choice survey in the UK, Germany and RomaniaGwenda Simons, Jorien Veldwijk, Rachael L DiSantostefano, et al.
BMC Rheumatology|March 20, 2019
Perceptions of first-degree relatives of patients with rheumatoid arthritis about lifestyle modifications and pharmacological interventions to reduce the risk of rheumatoid arthritis development: a qualitative interview studyGwenda Simons, Rebecca J Stack, Michaela Stoffer-Marx, et al.
BMJ Open|March 14, 2023
Treatment preferences for preventive interventions for rheumatoid arthritis: protocol of a mixed methods case study for the Innovative Medicines Initiative PREFER projectMarie Falahee, Gwenda Simons, Rachael L DiSantostefano, et al.
RMD Open|January 4, 2023
Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk toleranceGwenda Simons, Ellen M Janssen, Jorien Veldwijk, et al.
BMJ Open|July 1, 2016
Perceptions of risk and predictive testing held by the first-degree relatives of patients with rheumatoid arthritis in England, Austria and Germany: a qualitative studyRebecca J Stack, Michaela Stoffer, Mathias Englbrecht, et al.
Pageof 4